Spots Global Cancer Trial Database for extensive stage small cell lung cancer
Every month we try and update this database with for extensive stage small cell lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer | NCT00104793 | Lung Cancer | carboplatin irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer | NCT00282022 | Lung Cancer | laromustine | 18 Years - | National Cancer Institute (NCI) | |
| Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34 | NCT01176487 | Lung Cancer | questionnaire a... quality-of-life... 3-dimensional c... palliative radi... whole-brain rad... | 18 Years - | Cancer Trials Ireland | |
| MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer | NCT05903092 | Small Cell Lung... SCLC Extensive Stage... | Durvalumab Monalizumab Carboplatin or ... Etoposide | 18 Years - | Hoosier Cancer Research Network | |
| VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer | NCT00282022 | Lung Cancer | laromustine | 18 Years - | National Cancer Institute (NCI) | |
| Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer | NCT00087048 | Lung Cancer | topotecan hydro... | 18 Years - | Case Comprehensive Cancer Center | |
| A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa | NCT00119613 | Small Cell Lung... | placebo darbepoetin alf... | 18 Years - | Amgen | |
| Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer | NCT04699838 | Extensive Stage... | Cisplatin Carboplatin Etoposide Durvalumab Ceralasertib | 18 Years - | Big Ten Cancer Research Consortium | |
| A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer | NCT06323265 | Extensive Stage... | Adebrelimab + c... ±chest radiothe... | 18 Years - | Hebei Medical University Fourth Hospital | |
| Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00020007 | Lung Cancer Metastatic Canc... | isolated perfus... paclitaxel hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
| Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer | NCT00061919 | Lung Cancer | Carboplatin, et... Carboplatin, et... | 18 Years - | University College, London | |
| Dalteparin in Preventing Blood Clots in Patients With Lung Cancer | NCT00519805 | Lung Cancer Thromboembolism | dalteparin quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers | NCT00684801 | Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | questionnaire a... quality-of-life... | 18 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. | NCT00003943 | Carcinoma of Un... Lung Cancer | filgrastim carboplatin cyclophosphamid... paclitaxel topotecan hydro... peripheral bloo... | 18 Years - | Fox Chase Cancer Center | |
| Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body | NCT01325753 | Advanced Malign... Extensive Stage... Lung Metastases Recurrent Malig... Recurrent Non-s... Recurrent Small... Stage IV Non-sm... | cryotherapy quality-of-life... | 18 Years - | Wake Forest University Health Sciences | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer | NCT04699838 | Extensive Stage... | Cisplatin Carboplatin Etoposide Durvalumab Ceralasertib | 18 Years - | Big Ten Cancer Research Consortium | |
| Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | NCT00003674 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Veno-occlusive ... | dalteparin standard therap... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | NCT00031681 | Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas... | 7-hydroxystauro... irinotecan hydr... diagnostic labo... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00469898 | Lung Cancer | Carboplatin irinotecan hydr... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer | NCT00754858 | Lung Cancer | belotecan hydro... cisplatin | 18 Years - 75 Years | Yonsei University | |
| Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | NCT00002822 | Lung Cancer | carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide mesna vincristine sul... radiation thera... | - | National Cancer Institute (NCI) | |
| ZD6474 in Treating Patients With Small Cell Lung Cancer | NCT00066313 | Lung Cancer | vandetanib adjuvant therap... | 16 Years - 120 Years | Sanofi | |
| A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC | NCT05896059 | Extensive Stage... | Tislelizumab Anlotinib | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer | NCT00182689 | Extensive Stage... Recurrent Small... | sorafenib tosyl... | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy | NCT00068289 | Lung Cancer | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer | NCT00433498 | Lung Cancer | carboplatin cisplatin etoposide phosp... pravastatin sod... | 18 Years - | University College, London | |
| Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer | NCT00253708 | Cancer | management of t... massage therapy pain therapy psychosocial as... quality-of-life... | 18 Years - 120 Years | Beth Israel Deaconess Medical Center | |
| Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | NCT00041171 | Adult Solid Tum... Breast Cancer Head and Neck C... Kidney and Urin... Male Reproducti... Thorax and Resp... | Hypericum perfo... docetaxel placebo | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | NCT00388089 | Lung Cancer Unspecified Adu... | bortezomib topotecan hydro... flow cytometry immunoenzyme te... immunohistochem... laboratory biom... | 18 Years - | University of California, Davis | |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00004095 | Bladder Cancer Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Pancreatic Canc... | gemcitabine hyd... irinotecan hydr... | 18 Years - 120 Years | Northwestern University | |
| Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00248482 | Lung Cancer | Cisplatin Gleevec™ irinotecan | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy | NCT00068289 | Lung Cancer | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel in Treating Patients With Solid Tumors | NCT00003565 | Bladder Cancer Breast Cancer Head and Neck C... Lung Cancer Unspecified Adu... | docetaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer | NCT00104793 | Lung Cancer | carboplatin irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | NCT00433407 | Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... | trastuzumab | - | Jonsson Comprehensive Cancer Center | |
| Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer | NCT00433498 | Lung Cancer | carboplatin cisplatin etoposide phosp... pravastatin sod... | 18 Years - | University College, London | |
| Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00004186 | Lung Cancer | carboplatin etoposide ifosfamide topotecan hydro... radiation thera... | - | University of Alabama at Birmingham | |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | NCT00896467 | Anal Cancer Anxiety Disorde... Breast Cancer Depression Esophageal Canc... Gallbladder Can... Gastric Cancer Kidney Cancer Liver Cancer Lung Cancer Pancreatic Canc... Small Intestine... | questionnaire a... psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer | NCT03850067 | Small Cell Lung... | CC-90011 Cisplatin Carboplatin Etoposide Nivolumab | 18 Years - | Celgene | |
| PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer | NCT00544674 | Lung Cancer | PR104 F-18-fluoromiso... | 18 Years - | Proacta, Incorporated | |
| Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer | NCT04933175 | Extensive Stage... | Fluzoparil Anlotinib | 18 Years - 75 Years | Fujian Provincial Hospital | |
| Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00003299 | Lung Cancer | cisplatin etoposide paclitaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | NCT00019084 | Breast Cancer Cervical Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | aldesleukin mutant p53 pept... ras peptide can... sargramostim therapeutic aut... therapeutic tum... | 18 Years - | National Cancer Institute (NCI) | |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00303901 | Lung Cancer Metastatic Canc... | cryosurgery positron emissi... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer | NCT00006344 | Lung Cancer | radiation thera... | - | Virginia Commonwealth University | |
| Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00004186 | Lung Cancer | carboplatin etoposide ifosfamide topotecan hydro... radiation thera... | - | University of Alabama at Birmingham | |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers | NCT01935336 | Adenocarcinoma ... Extensive Stage... Limited Stage S... Recurrent Non-s... Recurrent Small... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... | Ponatinib | 18 Years - | University of Colorado, Denver | |
| R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | NCT00544596 | Extensive Stage... Unspecified Adu... | R-(-)-gossypol ... cisplatin etoposide | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00004095 | Bladder Cancer Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Pancreatic Canc... | gemcitabine hyd... irinotecan hydr... | 18 Years - 120 Years | Northwestern University | |
| Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer | NCT00884598 | Brain and Centr... Lung Cancer | cilengitide pharmacological... radiation thera... | 18 Years - | Universitätsmedizin Mannheim | |
| A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC | NCT05896059 | Extensive Stage... | Tislelizumab Anlotinib | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00083161 | Lung Cancer | cisplatin cyclophosphamid... etoposide | 18 Years - | Gundersen Lutheran Health System | |
| Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer | NCT00470054 | Extensive Stage... Limited Stage S... Recurrent Small... | dasatinib | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00227565 | Lung Cancer | carboplatin pemetrexed diso... radiation | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer | NCT00009971 | Lung Cancer | fenretinide | 18 Years - | National Cancer Institute (NCI) | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT01155258 | Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M... | temsirolimus vinorelbine dit... | 18 Years - | University of Southern California | |
| Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00053300 | Lung Cancer | thalidomide adjuvant therap... | 18 Years - | Case Comprehensive Cancer Center | |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | NCT00019825 | Esophageal Canc... Lung Cancer Malignant Mesot... Metastatic Canc... | decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer | NCT00003696 | Lung Cancer | carboplatin cyclophosphamid... doxorubicin hyd... etoposide paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | NCT00769990 | Breast Cancer Kidney Cancer Lung Cancer Melanoma Metastatic Canc... Pain Prostate Cancer | genistein radiation thera... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers | NCT01935336 | Adenocarcinoma ... Extensive Stage... Limited Stage S... Recurrent Non-s... Recurrent Small... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... | Ponatinib | 18 Years - | University of Colorado, Denver | |
| Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer | NCT00900835 | Breast Cancer Colorectal Canc... Fatigue Lung Cancer Pain Prostate Cancer | educational int... questionnaire a... study of socioe... assessment of t... fatigue assessm... quality-of-life... standard follow... | 18 Years - | City of Hope Medical Center | |
| ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer | NCT06052423 | Extensive Stage... | HS-20093 | 18 Years - | Hansoh BioMedical R&D Company | |
| Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer | NCT00416689 | Breast Cancer Lung Cancer Nausea and Vomi... | assessment of t... quality-of-life... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT01155258 | Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M... | temsirolimus vinorelbine dit... | 18 Years - | University of Southern California | |
| 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer | NCT00098956 | Extensive Stage... Recurrent Small... | topotecan hydro... 7-hydroxystauro... | 18 Years - | National Cancer Institute (NCI) | |
| Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer | NCT02675088 | Carcinoma, Smal... Lung Neoplasms | high-dose TRT standard-dose T... | 18 Years - 70 Years | ChineseAMS | |
| Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer | NCT01262560 | Dysphagia Lung Cancer Pain Esophagitis | Manuka honey in... Manuka honey in... Standard suppor... | 18 Years - | Radiation Therapy Oncology Group | |
| Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00052494 | Lung Cancer | cisplatin imatinib mesyla... irinotecan hydr... | - | University Health Network, Toronto | |
| Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00303901 | Lung Cancer Metastatic Canc... | cryosurgery positron emissi... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00041054 | Lung Cancer | carboplatin etoposide exisulind | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer | NCT00104754 | Lung Cancer | liposomal SN-38 | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | NCT00078845 | Breast Cancer Lung Cancer Neurotoxicity Ovarian Cancer Prostate Cancer Unspecified Adu... | Amifostine | 18 Years - | M.D. Anderson Cancer Center | |
| MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00869752 | Lung Cancer | anti-IGF-1R rec... cisplatin etoposide | 18 Years - | Canadian Cancer Trials Group | |
| Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC | NCT05001412 | Extensive Stage... | Camrelizumab; a... | 18 Years - 75 Years | Guangzhou Institute of Respiratory Disease | |
| A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer | NCT03850067 | Small Cell Lung... | CC-90011 Cisplatin Carboplatin Etoposide Nivolumab | 18 Years - | Celgene |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
